Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06024226

Role of MDSCs and Cancer Stem Cells and Their Cross Talks in NSCLC

Sponsor: University Hospital, Bordeaux

View on ClinicalTrials.gov

Summary

Immunotherapy have revolutionized the field of oncology, but response rates are low and all patients relapse, due to cellular and soluble immunosuppressive mechanisms. MDSC are one of the most important immunosuppressive cells, that also harbour non immunologic functions, favouring cancer invasion. These non immunologic functions of MDSC in lung cancer will be better characterized. Indeed, cellular mechanisms will be analysed by in vitro studies, assessing the effect of immunosuppressive cells, provided by fresh tumor samples, on phenotype and functions of lung cancer cell lines. The aim of this study is to better characterize immunosuppressive landscape of NSCLC and mechanisms involved in their protumor functions.

Official title: Role of Myeloid Derived Suppressive Cells (MDSCs) and Cancer Stem Cells and Their Cross Talks in Non-Small Cell Lung Cancer (NSCLC)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

10

Start Date

2025-12

Completion Date

2027-12

Last Updated

2025-07-30

Healthy Volunteers

No

Interventions

PROCEDURE

Tumor samples

Tumor samples will be collected by the pathologist at the reception of the tumor removed during surgery

Locations (1)

CHU de Bordeaux - Hôpital Saint-André, Service d'Oncologie Médicale

Bordeaux, France